CLN6
Basic information
Region (hg38): 15:68206992-68257211
Links
Phenotypes
GenCC
Source: 
- ceroid lipofuscinosis, neuronal, 6A (Definitive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6A (Strong), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6B (Kufs type) (Strong), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6A (Definitive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6B (Kufs type) (Supportive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6A (Supportive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6A (Definitive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6B (Kufs type) (Definitive), mode of inheritance: AR
 - ceroid lipofuscinosis, neuronal, 6A (Strong), mode of inheritance: AR
 - neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR
 
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Ceroid lipofuscinosis, neuronal, 6A; Ceroid lipofuscinosis, neuronal, 6B | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic; Ophthalmologic | 13822848; 5478271; 760366; 3284607; 7668317; 10929274; 11791207; 11727201; 15965709; 15996215; 19520283; 21549341; 21990111; 22883287; 23180398; 23735787; 30561534 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Neuronal_ceroid_lipofuscinosis (607 variants)
 - not_provided (157 variants)
 - Ceroid_lipofuscinosis,_neuronal,_6A (109 variants)
 - Ceroid_lipofuscinosis,_neuronal,_6B_(Kufs_type) (61 variants)
 - Inborn_genetic_diseases (60 variants)
 - not_specified (59 variants)
 - CLN6-related_disorder (10 variants)
 - Adult_neuronal_ceroid_lipofuscinosis (7 variants)
 - See_cases (3 variants)
 - Abnormality_of_the_nervous_system (3 variants)
 - Neurodevelopmental_disorder (2 variants)
 - Abnormal_brain_morphology (1 variants)
 - Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy (1 variants)
 - Neuronal_Ceroid-Lipofuscinosis,_Recessive (1 variants)
 - Spastic_ataxia (1 variants)
 - Cystic_fibrosis (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLN6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017882.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 218 | 218 | ||||
| missense | 38 | 191 | 14 | 251 | ||
| nonsense | 17 | 26 | ||||
| start loss | 2 | 2 | 4 | |||
| frameshift | 29 | 13 | 43 | |||
| splice donor/acceptor (+/-2bp) | 18 | 20 | ||||
| Total | 57 | 79 | 193 | 232 | 1 | 
Highest pathogenic variant AF is 0.00007322608
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| CLN6 | protein_coding | protein_coding | ENST00000249806 | 7 | 50220 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 0.000100 | 0.818 | 125706 | 0 | 42 | 125748 | 0.000167 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.00922 | 176 | 176 | 1.00 | 0.0000118 | 2031 | 
| Missense in Polyphen | 63 | 77.451 | 0.81342 | 932 | ||
| Synonymous | -2.53 | 102 | 74.3 | 1.37 | 0.00000525 | 633 | 
| Loss of Function | 1.23 | 8 | 12.7 | 0.628 | 5.62e-7 | 149 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000582 | 0.000582 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.0000544 | 0.0000544 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.000141 | 0.000141 | 
| Middle Eastern | 0.0000544 | 0.0000544 | 
| South Asian | 0.000163 | 0.000163 | 
| Other | 0.000163 | 0.000163 | 
dbNSFP
Source: 
- Disease
 - DISEASE: Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]: A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 6 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269|PubMed:11727201, ECO:0000269|PubMed:11791207, ECO:0000269|PubMed:12673792, ECO:0000269|PubMed:12815591, ECO:0000269|PubMed:19201763, ECO:0000269|PubMed:21990111, ECO:0000269|Ref.2}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ceroid lipofuscinosis, neuronal, 4A (CLN4A) [MIM:204300]: An adult-onset neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. CLN4A has no visual involvement and is characterized by progressive myoclonic epilepsy. {ECO:0000269|PubMed:21549341}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
 
Recessive Scores
- pRec
 - 0.205
 
Intolerance Scores
- loftool
 - 0.171
 - rvis_EVS
 - -0.07
 - rvis_percentile_EVS
 - 48.54
 
Haploinsufficiency Scores
- pHI
 - 0.217
 - hipred
 - N
 - hipred_score
 - 0.443
 - ghis
 - 0.595
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - E
 - gene_indispensability_score
 - 0.599
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Cln6
 - Phenotype
 - hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
 
Gene ontology
- Biological process
 - ganglioside metabolic process;lysosome organization;lysosomal lumen acidification;visual perception;cholesterol metabolic process;protein catabolic process;glycosaminoglycan metabolic process;locomotion involved in locomotory behavior;cellular macromolecule catabolic process;positive regulation of proteolysis
 - Cellular component
 - endoplasmic reticulum;endoplasmic reticulum lumen;endoplasmic reticulum membrane;membrane;integral component of membrane
 - Molecular function
 - protein binding;protein homodimerization activity